Exploring Bioinformatics Solutions for Improved Leishmaniasis Diagnostic Tools: A Review
Natáli T Capistrano Costa1, Allana M de Souza Pereira2, Cibele C Silva2
1Medicinal Theoretical Chemistry Laboratory, Department of Pharmaceutical Sciences, Health Sciences Center, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil.
Molecules (Basel, Switzerland)
|November 27, 2024
Summary
Leishmaniases diagnosis can be improved using bioinformatics to identify new antigens. This approach enhances accuracy, aiding in early detection and better treatment for affected populations.
Area of Science:
- Parasitology
- Bioinformatics
- Tropical Medicine
Background:
- Leishmaniases, caused by *Leishmania* parasites, affect tropical and subtropical regions.
- Accurate diagnosis is crucial for treatment, transmission control, and patient quality of life.
- Current diagnostic methods have limitations, including cross-reactivity and variable sensitivity/specificity.
Purpose of the Study:
- To review *in silico* tools for identifying diagnostic antigens for leishmaniases.
- To evaluate the efficacy and applications of these bioinformatics tools.
- To optimize the selection of specific molecules for improved leishmaniasis diagnosis.
Main Methods:
- Bioinformatics approaches for *in silico* antigen discovery.
- Epitope selection and antibody-antigen interaction prediction.
- Docking analysis for evaluating antigen-antibody complexes.
Main Results:
- Recombinant antigens generated via bioinformatics show increased diagnostic accuracy.
- Bioinformatics tools offer an effective technique for identifying potential new antigens.
- These methods facilitate earlier and more precise leishmaniasis diagnosis.
Conclusions:
- Bioinformatics is a valuable approach for developing more accurate leishmaniasis diagnostics.
- The review highlights key *in silico* tools for antigen selection.
- Optimized antigen selection using these tools can lead to more effective diagnostic strategies.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...